Tianjin Medical Journal ›› 2019, Vol. 47 ›› Issue (9): 994-997.doi: 10.11958/20190062

Previous Articles     Next Articles

Progress in research of clonal evolution of acquired aplastic anemia

DING Yu-bin1, TANG Yu-feng2, TANG Xu-dong1△   

  1. 基金项目:国家中医药管理局中医药行业科研专项(201507001-13);国家自然科学基金青年基金资助(81303127);国家自然科学基金面 上项目(81673819) 作者单位:1中国中医科学院西苑医院血液科(邮编100091),2检验科 作者简介:丁宇斌(1993),男,博士在读,主要从事再生障碍性贫血的研究 △通讯作者 E-mail: tangxudong001@163.com
  • Received:2019-01-07 Revised:2019-06-17 Published:2019-09-15 Online:2019-09-18

Abstract: Acquired aplastic anemia (AA) is an immune-mediated bone marrow failure disease. Clonal hematopoiesis can be seen in hematopoietic stem cells in more than 70% of AA patients. Common somatic mutations such as the deletion of PIGA gene and HLA allele in AA may be closely related to its immunopathological mechanism. Older age, shortened telomeres in leukocytes and HLA class Ⅰ risk alleles in AA may promote clonal evolution. The course, gene mutation and cytogenetic abnormalities of AA play a key role in the transformation of AA to myelodysplastic syndrome (MDS). Based on the latest research progress of AA cloning evolution and the report of the 60th Annual Conference of American Society of Hematology, this paper reviews the origin, selection and evolution of AA clone. The influencing factors of AA clone evolution and the risk factors of AA transforming into MDS are discussed emphatically.

Key words: anemia, aplastic, HLA antigens, alleles, telomere, clonal evolution